Cancer stem cells: how can we target them?

Area of Science:

• Oncology
• Cancer Stem Cell Biology
• Tumorigenesis

Background:

• The cancer stem cell (CSC) hypothesis posits that a small population of self-renewing cells drives tumor initiation and progression.
• CSCs are implicated in various cancers, including hematological malignancies and solid tumors like breast, brain, colon, and pancreatic cancer.
• CSCs exhibit resistance to conventional therapies, contributing to treatment failure and relapse.

Purpose of the Study:

• To review the concept of cancer stem cells and their role in tumor biology.
• To summarize advancements in targeting cancer stem cells for improved cancer therapy.
• To highlight the potential of CSC targeting in the drug discovery process.

Main Methods:

• Review of existing literature on cancer stem cells.
• Analysis of molecular mechanisms underlying CSC resistance to therapy.
• Exploration of therapeutic strategies targeting CSCs.

Main Results:

• Cancer stem cells possess inherent resistance to chemotherapy and radiotherapy, similar to somatic stem cells.
• Reactivation of developmental signaling pathways (e.g., EGF/EGFR, Notch, Wnt) and enhanced DNA repair contribute to CSC resistance.
• The tumor microenvironment also influences CSC behavior and therapeutic response.

Conclusions:

• Targeting cancer stem cells is crucial for enhancing the efficacy of current anti-cancer strategies.
• Molecular targeting of CSCs can sensitize tumors to conventional therapies and abrogate tumorigenesis.
• Further research into CSC targeting holds significant promise for novel drug discovery and improved cancer treatment outcomes.